Health behavior change program for people at high risk of colorectal cancer
Official title: Facilitating Health Behavior Change in High-Risk Individuals for Colorectal Cancer: A Randomized Controlled Trial
Run by China Medical University, China · NCT07262840 · Data updated 2026-11-12
This project will test a 12-week support program to help adults at high risk for colorectal cancer improve diet, exercise, and other lifestyle habits.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Months to 80 Months |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | China Medical University, China Academic / other |
| Locations | 1 site (Shenyang, Liaoning) |
| Status | Recruiting |
| Started | November 10, 2025 |
| Main results expected | February 10, 2026 |
| Study ends | February 10, 2026 |
| Registry record updated | December 4, 2025 |
| Trial ID | NCT07262840 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 years or older identified as high-risk for colorectal cancer per NCCN and relevant Chinese consensus, who can communicate, give informed consent, and have no prior cancer or severe psychiatric disorder.
✕Probably not a fit
Individuals with a prior cancer diagnosis, severe psychiatric disorders, or those unable or unwilling to attend program sessions are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized interventional study will enroll adults identified as high-risk for colorectal cancer and assign them to either a 12-week multi-component health promotion program or standard care. The intervention combines education, behavior-change techniques, and lifestyle counseling targeting diet, physical activity, smoking, and alcohol use to build knowledge and self-efficacy. Outcomes include changes in lifestyle behaviors, colorectal cancer knowledge, and confidence to maintain healthy habits measured after the 12-week program. The study is conducted at the School of Nursing, China Medical University, and uses national and NCCN criteria to identify eligible high-risk participants.
Why it matters
Potential benefit: If successful, the program could help high-risk adults adopt and maintain healthier behaviors that may lower their colorectal cancer risk.
How similar studies have gone: Previous lifestyle and health-promotion programs have produced modest improvements in diet, physical activity, and smoking cessation in at-risk groups, though direct evidence of reduced colorectal cancer incidence is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Meets the criteria for being at high-risk for colorectal cancer as defined by the US National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for Colorectal Cancer Screening and the relevant Chinese expert consensus on colorectal cancer diagnosis and treatment. * Age ≥ 18 years. * Has normal verbal communication and comprehension abilities. * Provides informed consent and voluntarily agrees to participate in the study. Exclusion Criteria: * Has a prior diagnosis of any malignancy (cancer). * Has a diagnosed severe psychiatric or psychological disorder.
Where it's running
-
School of Nursing, China Medical University
Shenyang, Liaoning, China Recruiting
Study contacts
- Study coordinator: Jialin Li
- Email: lijlpanda@163.com
- Phone: 15909836297
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Biomarkers in Colorectal Cancer: A Longitudinal Study Using Biobanks and Blood Samples
This study tests whether clinical and molecular biomarkers from tumor tissue and blood can predict treatment response, recurrence, and survival in adults with colorectal cancer undergoing surgery.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
ctDNA blood test to spot buried cancer after surgery or treatment in colorectal cancer
A blood test that looks for specific KRAS mutations in circulating tumor DNA to see if colorectal cancer has left residual disease or is likely to relapse.
-
Sleep Better, Live Better: a 12-week coaching program to help adults improve sleep and heart-brain health
This trial tests a 12-week, telephone- and text-based sleep coaching program for adults 25–65 with short sleep and higher cardiometabolic risk to see if it improves sleep and related behaviors.
-
Multimodal Survival Predictor for Colorectal Liver Metastases After Surgery
Researchers are testing a tool that combines MRI-derived tumor features with clinical data to predict survival after surgery for colorectal liver metastases.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.